Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers June 22, 2018
Pharmacy Choice - News - Generic Drugs - June 22, 2018

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 78     Next >>     Go To Page:

6/21/18 - Active Pharmaceutical Ingredients Market 2018; Relish Tremendous Growth at a CAGR of 4.93% | Achieve Share worth USD 215 Billion by 2023 Avail at MRFR
"Active Pharmaceutical Ingredients Market" The report titled Global Active Pharmaceutical Ingredients Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. And also cover the other information such as Active Pharmaceutical
6/21/18 - Biosimilars Market Estimated to Generate USD 13.1 Billion by 2024 | Hexa Research
Research Report on Biosimilars Market Size, Growth Rate, Price Trends, Application Analysis, Competitive Market Strategies and Forecasts, 2014- 2024. The global Biosimilars Market is expected to reach USD 13.1 billion by 2024 on account of increase in the prevalence of chronic diseases such as cancer, diabetics, cardiac disorders and autoimmune dis
6/21/18 - Biosimilars Market Global Size 2018; Generate Unsurpassed Growth at A CAGR Of 26 % | By Product Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Etc. - By 2023
The report titled Global Biosimilars Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. The market for biosimilars is anticipated to earn USD 16.97 Billion by 2023 from USD 3.35 Billion in 2016 while growing at a CAGR o
6/21/18 - Biosimilars Market Global Size 2018; Generate Unsurpassed Growth at A CAGR Of 26 % | By Product Recombinant Glycosylated Proteins, Recombinant Non-Glycosylated Proteins, Etc. By 2023
"Biosimilars Market" The report titled Global Biosimilars Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover market size, growth rate, opportunities, market Dynamics and Factor Analysis. The market for biosimilars is anticipated to earn USD 16.97 Billion by 2023 from USD 3.35 Billion in 2016 whil
6/21/18 - FDA scraps biosimilars draft guidance
In an effort to reduce the cost and increase the efficiency of biosimilars development, FDA Thursday withdrew draft guidance on statistical approaches for evaluating analytical similarities between a proposed biosimilar and its reference product. FDA plans to issue new draft guidance that "will reflect state-of-the-art techniques in the evaluation
6/21/18 - Mylan Launches Generic Angiomax Injection
HERTFORDSHIRE- Global pharmaceutical company Mylan N.V. today announced the U.S. launch of Bivalirudin for Injection, 250 mg single-dose vial, a generic version of Angiomax from The Medicines Company. Mylan is offering Bivalirudin for Injection, 250 mg single-dose vial, to its hospital and institutional customers after an Abbreviated New Drug Appli
6/21/18 - Senate Sends Jackson Generic Drug Bill to the Governor's Desk
The Maine Senate Democrats issued the following news:. On Wednesday, the Maine Senate voted 18-13 to enact legislation from Senate Democratic Leader Troy Jackson of Allagash, which aims to lower the cost of prescription medicine by increasing the availability of more affordable generic drugs. LD 1280 would amend the Maine Pharmacy Act to require th
6/21/18 - Supply of Generic Drugs for a Period of Two Years from the Date of Conclusion of Rate Contract
Company: DIRECTORATE GENERAL HEALTH SERVICES, MHFW. Ministry/Department Ministry of Health and Family Welfare Govt Medical Store Depot C-4 Qutub Institutional Area New Delhi-110016 Attn: Incharge Gmsd New Delhi. Description: Tenders are invited for Supply of Generic Drugs for a Period of Two Years from the Date of Conclusion of Rate Contract Work..
6/21/18 - Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05% [Ethiopian News Agency]
-Teligent, Inc., a New Jersey- based specialty generic pharmaceutical company, today announced it has received approval of the Companys abbreviated new drug application from the U.S. Food and Drug Administration of Fluocinonide Gel, 0.05%. Based on recent IQVIA data from April 2018, the total addressable market for this product is approximately $6.
6/21/18 - Tender Enquiry for Supply of Generic Drugs for a Period of Two Years from the Date of Conclusion of Rate Contract
Company: DIRECTORATE GENERAL HEALTH SERVICES, MHFW. Ministry/Department Ministry of Health and Family Welfare Govt Medical Store Depot C-4 Qutub Institutional Area New Delhi-110016 Attn: Incharge Gmsd New Delhi. Description: Tenders are invited for Tender Enquiry for Supply of Generic Drugs for a Period of Two Years from the Date of Conclusion of R
6/21/18 - The Pharmaceutical Industry in the United States 2018: Market Trends & Challenges, R&D, Patents and Leading Players
The "Pharmaceutical Industry in the United States 2018" report has been added to ResearchAndMarkets.com' s offering. The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs in the United States. The report brings you a complete analysis of the Pharmaceutical Industry in the United States 2018.
6/21/18 - The Pharmaceutical Industry in the United States 2018: Market Trends & Challenges, R&D, Patents and Leading Players - ResearchAndMarkets.com
The "Pharmaceutical Industry in the United States 2018" report has been added to ResearchAndMarkets.com' s offering. The pharmaceutical industry is under mounting scrutiny because of rapidly increasing expenditures for drugs in the United States. The report brings you a complete analysis of the Pharmaceutical Industry in the United States 2018.
6/21/18 - Unichem Pharma Announces Executive Leadership Change
Mr. Delaney has also been appointed as a member of the Company's Board of Directors. Mr. Delaney has worked with outstanding organizations such as Eli Lilly and Company, Johnson and Johnson, HEB Grocery Company, Teva Pharmaceuticals, URL Pharma, Cadista Pharmaceuticals, and Edenbridge Pharmaceuticals. Most recently, Mr. Delaney was President of Her
6/20/18 - Amneal Announces Patent Litigation Settlement Agreement with Actavis Concerning Rytary
Amneal Pharmaceuticals, Inc., a specialty pharmaceutical company, today announced that it has entered into a settlement agreement with Actavis Laboratories FL, Inc. and Actavis Pharma Inc. resolving patent litigation related to Rytary . The litigation has been pending in the U.S. District Court for the District of New Jersey and resulted from A
6/20/18 - Challenges To Big Pharma Are Helping Drive The Bio-Pharmaceutical Logistics Market
LONDON, GREATER LONDON, UNITED KINGDOM, June 20, 2018/ EINPresswire.com/ Pharmaceutical companies are trying to reduce their distribution costs to help compensate for pressures resulting from the increase of low-cost generics, the fall of the blockbuster drug model, and a sharp increase in R&D costs. One result is the growth of the bio-pharmaceut
6/20/18 - Dr. Reddy's Laboratories announces USFDA final approval and launch of Buprenorphine and Naloxone Sublingual Film in the U.S. Market
HYDERABAD- Dr. Reddy's Laboratories Ltd. announced today that it has received final approval from the U.S. Food and Drug Administration and is launching Buprenorphine and Naloxone Sublingual Film, 2 mg/0. 5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg, a therapeutic equivalent generic version of Suboxone sublingual film, in the United States market.
6/20/18 - Germany-dsseldorf: Pharmaceutical Products [TendersInfo (India)]
Contract notice: Germany-Dsseldorf: Pharmaceutical products. conclusion of a generic discount contract for the above-mentioned active ingredient. time limit for receipt of tenders or requests to participate: Date: 30/07/2018 local time: 12:00 Major organization: GWQ SERVICEPLUS AG Address: Tersteegenstr. 28 Dsseldorf 40474 Country: Germany Email:..
6/20/18 - NOD TO FIRST PRODUCT FROM GLENMARK'S US PLANT
Glenmark Pharmaceuticals Limited has announced that the US Food and Drug. Administration has approved the first supplemental abbreviated new drug application from its plant in the US. The drug was produced at the company's manufacturing facility at Monroe in North Carolina.
6/20/18 - Novartis - Sandoz presents new long-term and switching data for biosimilars Zessly and Erelzi in rheumatoid arthritis
Holzkirchen- Sandoz, a Novartis division and the pioneer and global leader in biosimilars, today announced the presentation of two long-term, Phase III studies: one each for biosimilar Zessly, and biosimilar Erelzi.,. 'We are very pleased with these data, which reinforce what well over 10 years of science and real-world evidence in Europe have show
6/20/18 - Teligent, Inc. Announces FDA Approval of Fluocinonide Gel, 0.05%
Teligent, Inc., a New Jersey- based specialty generic pharmaceutical company, today announced it has received approval of the Company s abbreviated new drug application from the U.S. Food and Drug Administration of Fluocinonide Gel, 0.05%. Teligent is a specialty generic pharmaceutical company. Damian Finio Teligent, Inc. 856-336-9117 www.teli
6/20/18 - The US FDA Approves First Supplemental Abbreviated New Drug Application (sANDA) for Glenmark Pharmaceuticals' Manufacturing Facility in Monroe, North Carolina
The Monroe, North Carolina facility is Glenmark's first manufacturing site in the U.S., designed to manufacture a variety of fixed dose pharmaceutical formulations. Glenmark has invested more than $100 million into the facility with plans for further expansion in the coming years. Globally, Glenmark has 16 manufacturing facilities in Europe, India
6/20/18 - USFDA approves first product from Glenmark`s US plant [All Iraq News Agency (AIN)]
Glenmark Pharmaceuticals today said the US health regulator has approved the first product from its Monroe, North Carolina based manufacturing facility. The US Food and Drug Administration has provided its first supplemental Abbreviated New Drug Application approval for the company`s plant in Monroe, Glenmark said in a statement. "This approval is
6/19/18 - Accord Healthcare implements next generation of Ci-DMS [Tehran Times (Iran)]
As part of their process for Continuous Improvement, Accord Healthcare, has implemented the next generation of Ci-DMS MES from CI Precision, benefiting from increased efficiency and enhanced compliance. Accord Healthcare, one of the fastest growing generic pharmaceutical companies in the UK& Ireland, has an extensive supply chain through its four U
6/19/18 - Agenda Released for USA Biosimilars Conference this November
AMC BEGIN ABOUT> SMi Group Reports: The official agenda for the 5th annual Biosimilars USA conference, which is taking place this fall in New Jersey, USA, has been released.. This year s event will explore the developments in biosimilar drug development by gathering a global audience of biosimilar experts and industry-thought leaders to d
6/19/18 - Amphastar Announces Approval for Isoproterenol Hydrochloride Injection, USP
Amphastar Pharmaceuticals, Inc., announced that the U.S. Food and Drug Administration has granted approval of its abbreviated new drug application for Isoproterenol Hydrochloride Injection, USP 0.2 mg/mL, 1 mL and 0.2 mg/mL, 5 mL single dose vial. This approval further strengthens our vertical integration strategy, given that the Active Pharmaceu
Articles(s): 1 - 25 of 78     Next >>     Go To Page:


© 2018 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Legal & Practical Issues in Compounding Pharmacy
This lesson is supported by:
RxSchool
Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2018 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415